Literature DB >> 7507192

Idarubicin-containing regimen and G-CSF are capable of recruiting CD34+/DR- cells with high proliferative potential which sustain Ph-negative polyclonal hematopoiesis.

A M Carella, M Podestá, N Pollicardo, E Pungolino, M R Raffo, R Ferrero, G Bergamaschi, V Rosti, M Cazzola, G Saglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7507192

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  1 in total

Review 1.  New directions for the treatment of chronic myeloid leukaemia.

Authors:  J M Goldman
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.